Advertisement
Advertisement

CLNN

CLNN logo

Clene Inc. Common Stock

7.28
USD
Sponsored
-0.11
-1.49%
May 08, 16:00 UTC -4
Closed
exchange

After-Market

7.24

-0.04
-0.62%

Clene Inc. Common Stock Profile

About

Clene Inc. is a clinical-stage biopharmaceutical company. It is focused on the development of unique therapeutics for neurodegenerative diseases. Clene Nanomedicine Inc., formerly known as Tottenham Acquisition I Limited, is based in SALT LAKE CITY.

Info & Links

CEO

Robert Etherington

Headquarters

6550 SOUTH MILLROCK DRIVE, SUITE G50
SALT LAKE CITY, UT 84121, UNITED STATES

Industry

Medical Biomedical And Genetics

Sector

Medical

Website

https://clene.com

Auditor

Deloitte & Touche LLP

Share holders

59

Employees

79

Clene Inc. Common Stock Statistics

Valuation Measures

Market Capitalization2

85.22M

Enterprise Value

97.64M

Enterprise Value/EBITDA(ttm)

-4.52

Price to Earnings Ratio(ttm)

--

Price to Sales(ttm)

373.36

Price to Book(mrq)

--

Price to Cash(ytd)

--

Profitability

Gross Margin(ttm)

86.36%

Operating Margin(ttm)

-14915.00%

Profit Margin(ttm)

-24725.03%

Return on Equity(ttm)

--

Return on Invested Capital(ttm)

331.95%

Return on Assets(ttm)

-135.77%

Income Statement

Revenue(ttm)

200.00K

Revenue Per Share(ttm)

0.02

Gross Profit(ttm)

157.00K

EBITDA(ttm)3

-21.59M

Net Income Available to Common(ttm)

-26.17M

Diluted EPS(ttm)

-2.60

Share Statistics

Beta (5Y Monthly)

0.62

52-Week Change

182.17%

S&P 500 52-Week Change

26.60%

S&P 500 Member

Yes

Stock Optionable

Yes

Total Shares Outstanding1

11.78M

Dividend Yield

0.00%

Float4

7.62M

% Held by Insiders

35.30%

% Held by Institutions

23.28%

Balance Sheet

Total Cash(mrq)

5.19M

Total Cash Per Share(mrq)

0.44

Total Debt(mrq)

17.61M

Total Debt/Equity(mrq)

-100.13%

Current Ratio(mrq)

0.83%

Quick Ratio(mrq)

0.83%

Book Value Per Share(mrq)

-1.62

Cash Flow

Operating Cash Flow Per Share(ytd)

-1.88

Free Cash Flow(ytd)

-18.59M

Table Key

mrq = Most Recent Quarter

ttm = Trailing Twelve Months

ytd = Year To Date

Footnotes

Data provided by Zacks Investment Research or calculated by FXEmpire. All numbers are rounded to the closest decimal.

  • 1 Total Shares outstanding is taken from the most recently filed quarterly or annual report.
  • 2 Market Cap is calculated using total shares outstanding and the most recent share price.
  • 3 EBITDA is calculated using methodology that may differ from that used by a company in its reporting.
  • 4 The float is a measure of the number of shares available for trading by the public. It's calculated by taking the number of issued and outstanding shares minus any restricted stock, which might not be publicly traded.
Advertisement